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Reprints not available from the authors. To the Editor: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare but severe cutaneous hypersensitivity reaction that typically occurs 2 to 8 weeks after continuous exposure to an offending agent (medication). The diagnosis can be challenging and is largely clinical, with manifestations that can include fever, rash, lymphadenopathy, eosinophilia, and internal organ involvement. 1 Current understanding of the pathogenesis, triggers, and predisposing factors for DRESS is incomplete. Several classes of medications have been implicated, including antibiotics, anticonvulsants, and antiretrovirals. 2 The majority of retrospective studies have been published by groups in Asia, and whether these reviews are (Table I ). All cases were diagnosed by using RegiSCAR criteria and the expertise of 1 inpatient dermatologist. Identifying the culprit can be challenging, and no specific criteria such as the Naranjo Scale was used. However, the likely drug culprit was determined after careful review of a complete drug time line that included all known current and recent medication exposures.
Antibiotics were the most common cause of DRESS in our cohort; they were responsible for 63% of cases (Fig 1) . Vancomycin was the most common antibiotic culprit, accounting for 60% of antibiotic-associated cases. This is in contrast to frequent reports of allopurinol and carbamazepine as the most common DRESS-inducing agents.
2 A 2016 systematic review by Minhas et al of vancomycin-induced hypersensitivities from 1982 to 2015 identified 16 cases of DRESS associated with vancomycin. 3 Our study alone identified 12 cases within the span of 3 years. The increased prevalence of vancomycin-induced DRESS at our institution may reflect increased use of vancomycin or a possible link between our patient population and sensitivity to the drug. Of our 12 vancomycinrelated cases, the most common race identified was white (8 patients [67%]). Half of our patients also identified as Hispanic or Latino (6 patients [50%]).
A retrospective review by Magill et al from 2011 found that parenteral vancomycin is the most commonly used antibiotic in acute care hospitals to treat both community-onset and hospital-acquired infections in both critical care and nonecritical care settings. 4 The increasing popularity of vancomycin has been a concern for some time because of the role that injudicious use plays in antibiotic resistance. Association with DRESS adds further evidence to the argument for conservative use.
In addition to eliminating unnecessary use, identifying populations that are particularly susceptible to vancomycin-induced DRESS may help physicians practice safer medicine. To date, we have a limited understanding of what predisposes patients to DRESS. One theory is that susceptible patients have a genetic deficiency in the enzymes needed to metabolize certain drugs. 1 It is also thought that certain human leukocyte antigens may predispose patients to hypersensitivity reactions. 5 Further research is needed to investigate whether and why certain drugs cause DRESS in different patient populations. 
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Implementation of a dermatology teletriage system to improve access in an underserved clinic: A retrospective study
To the Editor: Access to dermatologic care is especially limited for uninsured patients. 1 Puentes de Salud (Bridges of Health) is a multidisciplinary clinic that provides primary and specialty care to an uninsured and underserved population of mostly Latino immigrants in Philadelphia, Pennsylvania. Local dermatologists volunteer to support 1 clinic per month, but the volume of dermatology referrals led to significant wait times and delayed patient care. Teledermatology is a well-established and accurate 2 tool for remote diagnosis and management that increases access 3 to dermatology care; however, its use for triage in underserved clinics has not been formally evaluated. We implemented a store-andforward teledermatology triage system with goals of expanding access, reducing time to dermatologist 
